Business Details
Innovative Drug Delivery Solutions for Improved Patient Outcomes
At Antares Pharma, we are dedicated to transforming patient care through innovative drug delivery technologies and FDA-approved therapeutic solutions. Our ENHANZE technology, built on proprietary enzyme rHuPH20, revolutionizes subcutaneous drug administration by reducing treatment times from hours to minutes. With over three decades of expertise in auto-injector device development, we design patient-centric solutions that address evolving therapeutic needs. Our commercial portfolio includes two FDA-approved products, HYLENEX and XYOSTED, which exemplify our commitment to improving treatment accessibility and outcomes.Guided by core values of integrity, inclusivity, and scientific excellence, we collaborate with partners to advance therapies that simplify care protocols and enhance patient quality of life. Our leadership team combines deep industry experience with a shared vision of redefining healthcare delivery, while our corporate responsibility initiatives prioritize sustainability, diversity, and ethical practices across all operations.
Services
Drug Delivery Technologies
Auto-Injector Development
FDA-Approved Therapies
Subcutaneous Administration
Medical Device Engineering
Highlights and features
- We offer 30+ years of expertise in auto-injector device development.
- Our ENHANZE technology streamlines subcutaneous drug delivery for faster treatment.
- We commercialize two FDA-approved products with proven clinical efficacy.
- Our leadership team combines deep biopharma experience with innovative vision.
- We prioritize diversity, sustainability, and ethical practices in all operations.
Services
Drug Delivery Technologies
Our ENHANZE technology uses proprietary enzymes to enable rapid subcutaneous administration of high-volume drugs. This platform addresses limitations in traditional IV infusions by reducing treatment time while maintaining efficacy. We collaborate with partners to integrate this solution across therapeutic areas.
Auto-Injector Development
With 30+ years of experience, we design custom auto-injectors for subcutaneous and intramuscular use. Our engineering team creates patient-friendly devices that improve medication adherence through intuitive delivery mechanisms tailored to specific therapeutic needs.
FDA-Approved Therapies
We market HYLENEX (hyaluronidase human injection) and XYOSTED (testosterone enanthate), both FDA-cleared treatments. These products demonstrate our commitment to delivering safe, effective therapies that address unmet medical needs through innovative formulation approaches.
People
Helen Torley
President and Chief Executive Officer
Helen Torley leads Antares Pharma with extensive biopharmaceutical experience, driving strategic growth and innovation in drug delivery technologies to enhance patient care globally.
Nicole LaBrosse
Chief Financial Officer
Nicole LaBrosse oversees financial strategy at Antares Pharma, bringing expertise in biotech finance to support sustainable growth and operational excellence.
Charles Theuer
Chief Medical Officer
Dr. Charles Theuer directs medical strategy at Antares Pharma, leveraging his clinical and research background to advance therapeutic development and patient-focused care initiatives.
Questions
What is Halozyme's primary focus?
We specialize in drug delivery technologies and commercializing FDA-approved therapies to improve patient treatment experiences.
What products does Halozyme offer?
Our portfolio includes ENHANZE technology and FDA-approved products HYLENEX and XYOSTED for specialized therapeutic applications.
How does ENHANZE technology work?
It uses proprietary enzymes to enable faster subcutaneous delivery of high-volume medications compared to traditional IV methods.
What therapeutic areas do you focus on?
We develop solutions across multiple therapeutic areas through partnerships and internal research initiatives.
